Sprint Bioscience Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sprint Bioscience
Access all reports
Sprint Bioscience AB is a Swedish biotechnology company focused on developing innovative cancer therapies. It specializes in drug discovery for oncology, leveraging a fragment-based drug discovery (FBDD) platform to accelerate the identification of promising molecules for cancer treatment. The company's research pipeline includes drug candidates targeting cancer metabolism and autophagy, with the aim of enhancing therapeutic approaches for hard-to-treat cancers. It is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SPRINT
Country
🇸🇪 Sweden